173 related articles for article (PubMed ID: 33367598)
1. Seroprevalence of Chlamydia trachomatis Among Female Adults in the United States: The National Health and Nutrition Examination Surveys.
Petersen MR; Patel EU; Grabowski MK; Gaydos CA; Quinn TC; Tobian AAR
Clin Infect Dis; 2021 Aug; 73(3):e629-e637. PubMed ID: 33367598
[TBL] [Abstract][Full Text] [Related]
2. Assessment and utility of 2 Chlamydia trachomatis Pgp3 serological assays for seroprevalence studies among women in the United States.
Danavall DC; Gwyn S; Anyalechi GE; Bowden KE; Hong J; Kirkcaldy RD; Bernstein KT; Kersh EN; Martin D; Raphael BH
Diagn Microbiol Infect Dis; 2021 Oct; 101(2):115480. PubMed ID: 34325205
[TBL] [Abstract][Full Text] [Related]
3. Chlamydia trachomatis Pgp3 Antibody Population Seroprevalence before and during an Era of Widespread Opportunistic Chlamydia Screening in England (1994-2012).
Woodhall SC; Wills GS; Horner PJ; Craig R; Mindell JS; Murphy G; McClure MO; Soldan K; Nardone A; Johnson AM
PLoS One; 2017; 12(1):e0152810. PubMed ID: 28129328
[TBL] [Abstract][Full Text] [Related]
4. High Plasmid Gene Protein 3 (Pgp3) Chlamydia trachomatis Seropositivity, Pelvic Inflammatory Disease, and Infertility Among Women, National Health and Nutrition Examination Survey, United States, 2013-2016.
Anyalechi GE; Hong J; Danavall DC; Martin DL; Gwyn SE; Horner PJ; Raphael BH; Kirkcaldy RD; Kersh EN; Bernstein KT
Clin Infect Dis; 2021 Oct; 73(8):1507-1516. PubMed ID: 34050737
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of Chlamydia trachomatis genital infection among persons aged 14-39 years--United States, 2007-2012.
Torrone E; Papp J; Weinstock H;
MMWR Morb Mortal Wkly Rep; 2014 Sep; 63(38):834-8. PubMed ID: 25254560
[TBL] [Abstract][Full Text] [Related]
6. Sera selected from national STI surveillance system shows Chlamydia trachomatis PgP3 antibody correlates with time since infection and number of previous infections.
Blomquist PB; Mighelsen SJ; Wills G; McClure E; Ades AE; Kounali D; Dunbar JK; McClure MO; Soldan K; Woodhall SC; Horner P
PLoS One; 2018; 13(12):e0208652. PubMed ID: 30557408
[TBL] [Abstract][Full Text] [Related]
7. Pgp3 antibody enzyme-linked immunosorbent assay, a sensitive and specific assay for seroepidemiological analysis of Chlamydia trachomatis infection.
Wills GS; Horner PJ; Reynolds R; Johnson AM; Muir DA; Brown DW; Winston A; Broadbent AJ; Parker D; McClure MO
Clin Vaccine Immunol; 2009 Jun; 16(6):835-43. PubMed ID: 19357314
[TBL] [Abstract][Full Text] [Related]
8. Development and evaluation of an enzyme-linked immunosorbent assay for the detection of antibodies to a common urogenital derivative of Chlamydia trachomatis plasmid-encoded PGP3.
Winstanley CE; Ramsey KH; Marsh P; Clarke IN
J Immunol Methods; 2017 Jun; 445():23-30. PubMed ID: 28283408
[TBL] [Abstract][Full Text] [Related]
9. Comparison of three serological assays to measure antibody response to Chlamydia antigen Pgp3 in adolescent and young adults with pelvic inflammatory disease.
Dize L; Martin D; Gwyn S; Perin J; Gaydos C; Trent M
Int J STD AIDS; 2018 Nov; 29(13):1324-1329. PubMed ID: 30049256
[TBL] [Abstract][Full Text] [Related]
10. Seroprevalence of Chlamydia trachomatis in Enugu, Nigeria.
Ikeme AC; Ezegwui HU; Ikeako LC; Agbata I; Agbata E
Niger J Clin Pract; 2011; 14(2):176-80. PubMed ID: 21860135
[TBL] [Abstract][Full Text] [Related]
11. C. trachomatis Pgp3 antibody prevalence in young women in England, 1993-2010.
Horner P; Soldan K; Vieira SM; Wills GS; Woodhall SC; Pebody R; Nardone A; Stanford E; McClure MO
PLoS One; 2013; 8(8):e72001. PubMed ID: 23991024
[TBL] [Abstract][Full Text] [Related]
12. Chlamydia trachomatis IgG seroprevalence in the general population of the Netherlands in 1996 and in 2007: differential changes by gender and age.
van Aar F; de Moraes M; Morré SA; van Bergen JE; van der Klis FR; Land JA; van der Sande MA; van den Broek IV
Sex Transm Infect; 2014 Aug; 90(5):434-40. PubMed ID: 24583966
[TBL] [Abstract][Full Text] [Related]
13. Effect of time since exposure to Chlamydia trachomatis on chlamydia antibody detection in women: a cross-sectional study.
Horner PJ; Wills GS; Reynolds R; Johnson AM; Muir DA; Winston A; Broadbent AJ; Parker D; McClure MO
Sex Transm Infect; 2013 Aug; 89(5):398-403. PubMed ID: 23430706
[TBL] [Abstract][Full Text] [Related]
14. A pilot study of the prevalence of chlamydial infection in a national household survey.
Mertz KJ; McQuillan GM; Levine WC; Candal DH; Bullard JC; Johnson RE; St Louis ME; Black CM
Sex Transm Dis; 1998 May; 25(5):225-8. PubMed ID: 9587171
[TBL] [Abstract][Full Text] [Related]
15. Pgp3 seroprevalence and associations with active trachoma and ocular Chlamydia trachomatis infection in Malawi: cross-sectional surveys in six evaluation units.
Burr SE; Hart J; Samikwa L; Chaima D; Cooley G; Martin D; Masika M; Solomon AW; Bailey RL; Kalua K
PLoS Negl Trop Dis; 2019 Oct; 13(10):e0007749. PubMed ID: 31658258
[TBL] [Abstract][Full Text] [Related]
16. Association between serum
Li P; Chen Z
Front Public Health; 2023; 11():1117245. PubMed ID: 37089503
[TBL] [Abstract][Full Text] [Related]
17. Chlamydia trachomatis trends in the United States among persons 14 to 39 years of age, 1999-2008.
Datta SD; Torrone E; Kruszon-Moran D; Berman S; Johnson R; Satterwhite CL; Papp J; Weinstock H
Sex Transm Dis; 2012 Feb; 39(2):92-6. PubMed ID: 22249296
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and persistence of
Öhman H; Rantsi T; Joki-Korpela P; Tiitinen A; Surcel HM
Sex Transm Infect; 2020 Jun; 96(4):277-282. PubMed ID: 31320394
[TBL] [Abstract][Full Text] [Related]
19. Trends in chlamydia prevalence in the United States, 2005-2016.
Cheng Y; Zheng G; Song Z; Zhang G; Rao X; Zeng T
Sci Rep; 2024 May; 14(1):11825. PubMed ID: 38783017
[TBL] [Abstract][Full Text] [Related]
20. Validation of immunoassays for the Chlamydia trachomatis antigen Pgp3 using a chimeric monoclonal antibody.
Goodhew B; Tang X; Goldstein J; Lee J; Martin D; Gwyn S
Sci Rep; 2023 May; 13(1):7281. PubMed ID: 37142607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
